Back to 
Parallax Volatility Advisers, L.P.
Parallax Volatility Advisers, L.P.
IBRX
Showing 0 of 2 quarters
Position history for Parallax Volatility Advisers, L.P.'s holdings in ImmunityBio, Inc.
No. Parallax Volatility Advisers exited its IBRX (ImmunityBio) position in Q3 2023. Its Q2 2023 13F listed 297 shares worth $826. Parallax Volatility Advisers first reported IBRX in Q2 2023 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.